Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ·Healthcare·Biotechnology
$2.50
-0.99%
Mkt Cap $152.65M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 26, 2026 | — | — | — | -$0.50 | -$0.41 | +18.00% | — | — |
| Q4 2025 Nov 12, 2025 | — | — | — | -$0.63 | -$0.44 | +30.16% | — | — |
| Q3 2025 Aug 12, 2025 | — | — | — | -$0.54 | -$0.68 | -25.93% | — | — |
| Q2 2025 May 13, 2025 | — | — | — | -$0.56 | -$0.48 | +14.29% | — | — |
| Q1 2025 Mar 27, 2025 | — | — | — | -$0.47 | -$0.62 | -31.91% | — | — |
| Q4 2024 Nov 12, 2024 | — | — | — | -$0.36 | -$0.50 | -38.89% | — | — |
| Q3 2024 Aug 13, 2024 | — | — | — | -$0.28 | -$0.34 | -21.43% | — | — |
| Q2 2024 May 14, 2024 | — | — | — | -$0.23 | -$0.25 | -8.70% | — | — |
| Q1 2024 Mar 26, 2024 | $15.00M | $290.00K | -98.07% | -$0.29 | -$0.29 | +0.00% | — | — |
| Q4 2023 Nov 13, 2023 | — | — | — | -$0.31 | -$0.24 | +22.58% | — | — |
| Q3 2023 Aug 8, 2023 | — | — | — | -$0.36 | -$0.28 | +22.22% | — | — |
| Q2 2023 May 9, 2023 | — | — | — | -$0.33 | -$0.28 | +15.15% | — | — |
| Q1 2023 Mar 27, 2023 | — | — | — | -$0.28 | -$0.32 | -14.29% | — | — |
| Q4 2022 Nov 14, 2022 | — | — | — | -$0.27 | -$0.26 | +3.70% | — | — |
| Q3 2022 Aug 15, 2022 | — | — | — | -$0.24 | -$0.25 | -4.17% | — | — |
| Q2 2022 May 16, 2022 | — | — | — | -$0.17 | -$0.23 | -35.29% | — | — |
| Q1 2022 Mar 28, 2022 | — | — | — | -$0.14 | -$0.42 | -200.00% | — | — |
| Q4 2021 Nov 15, 2021 | — | — | — | -$0.21 | -$0.10 | +52.38% | — | — |
| Q3 2021 Aug 16, 2021 | — | — | — | -$4.56 | -$7.91 | -73.46% | — | — |
| Q3 2021 Jul 2, 2021 | — | — | — | — | -$0.73 | — | — | — |